<DOC>
	<DOCNO>NCT00006274</DOCNO>
	<brief_summary>OBJECTIVES : I . Determine total energy expenditure term preterm infant well ill state use doubly label water method .</brief_summary>
	<brief_title>Study Energy Requirements Critically Ill Newborns</brief_title>
	<detailed_description>PROTOCOL OUTLINE : Patients assign one three group accord gestational age ( 24-28 week estimate gestational age ( EGA ) vs 29-34 week EGA vs 35 week EGA ) severity respiratory illness ( need high frequency ventilation v stable conventional ventilator setting extubated within past 24 hour vs need mechanical ventilation ) . Patients receive water label deuterium oxygen O 18 mouth gastrostomy tube day 1 7 . Urine sample collect prior first dose , 4-6 hour first dose , every 24 hour second dose . All urine collect 4-6 hour second dose . Samples analyze dual inlet isotope ratio mass spectrometry .</detailed_description>
	<mesh_term>Critical Illness</mesh_term>
	<mesh_term>Respiratory Distress Syndrome , Newborn</mesh_term>
	<mesh_term>Respiratory Distress Syndrome , Adult</mesh_term>
	<criteria>PROTOCOL ENTRY CRITERIA : Disease Characteristics Infants estimate gestational age ( EGA ) least 24 week respiratory illness high frequency ventilation ( HFOV ) meet following condition : Appropriate size gestational age ( AGA ) No congenital anomalies No medical complication , include seizure necrotizing enterocolitis OR Control infants EGA least 24 week Must meet 1 follow condition : Requirement stable conventional ventilator setting respiratory index score less 2.5 and/or extubated within past 24 hour No requirement mechanical ventilation Must meet follow condition : AGA No congenital anomalies No medical complication , include seizure necrotizing enterocolitis No document sepsis positive blood culture No supplemental oxygen use ( infant 35 week EGA ) Prior/Concurrent Therapy HFOV group : Concurrent surfactant , theophylline , inotrope ( vasopressor ) therapy allow Control group : No concurrent inotrope ( vasopressor ) therapy</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>120 Hours</maximum_age>
	<verification_date>December 2003</verification_date>
	<keyword>cardiovascular respiratory disease</keyword>
	<keyword>neonatal disorder</keyword>
	<keyword>rare disease</keyword>
	<keyword>respiratory distress syndrome</keyword>
</DOC>